Events for May 8, 2024

The specific goal for this meeting is to foster fruitful and creative interactions between researchers interested in applying these systems to genome engineering and related advances in a wide variety of organisms, together with scientists studying the basic biology of CRISPR-Cas and related bacterial defense systems.

All are welcome to register and join the 2022 DOE Joint Genome Institute (JGI) Genomics of Energy & Environment Meeting, which coincides with our 25th Anniversary. The JGI convenes this annual gathering of leaders from diverse disciplines to highlight how they are addressing the world’s most pressing energy and environmental challenges. Many of these presenters have been supported by the research infrastructure – DNA sequencing, synthesis, metabolomics, data analysis, and new technology developments – that the JGI offers through its User Programs on a competitive, peer-reviewed basis to the worldwide scientific community. This year’s Meeting, to be held August 29 – 31, will be a hybrid event ­– in person at Lawrence Berkeley National Laboratory (Berkeley Lab) – and virtually through the Social27 platform.

This year we are bringing the event back to be more commercially and strategically focused, where in an intimate setting attendees will have the opportunity to connect with the full cell & gene community, enabling a 360-degree view on the current landscape.   It’s the destination for those wanting to debate the challenges, explore the opportunities, and discover the latest innovations, all within Europe and the UK.  In a bespoke setting, attendees will have access to the complete European advanced therapies landscape from macro to micro.  It’s the only event to offer companies a credible platform to position their company and solutions as leading providers in the advanced therapies technology and services space, including being able to place their brand directly under the nose of key decision makers from across Europe and the UK. Hosted in London the event is positioned front and center of all the action within the European advanced therapies landscape.